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Since its identification as a target of the p53 transcription
factor, the 14-3-3s gene has attracted considerable atten-
tion (Hermeking et al, 1997). As 14-3-3s is epigenetically
silenced in many carcinomas, it is regarded as a tumor-
suppressive gene (reviewed in Hermeking, 2003). Experi-
mental removal of the 14-3-3s gene leads to an inability to
maintain a stable G2/M-arrest after DNA-damage and sen-
sitizes cells to DNA-damaging treatments commonly used
in cancer therapy (Chan et al, 1999; Lodygin et al, 2004). 14-
3-3s is also known as STRATIFIN/SFN, a name related to its
high expression in stratifying keratinocytes, where it was
identified first (Leffers et al, 1993). The 14-3-3 proteins reg-
ulate numerous cellular processes in all multi-cellular spe-
cies analyzed. In humans 7 isoforms of 14-3-3 proteins have
been described, which form dimers that bind to pro-
tein ligands following serine/threonine-phosphorylation of
two canonical 14-3-3-binding motifs, R(S/X)XpSXP and
RXXXpSXP, where pS represents phospho-serine or phos-
pho-threonine and X any amino acid. Association with 14-3-
3 proteins regulates the function of ligands by inter- and
intra-compartmental sequestration, activation/inactivation
of enzymatic activity and promotion/inhibition of protein in-
teractions (reviewed in Hermeking, 2003).
Studies of human keratinocytes have shown that 14-3-
3s expression is induced during the exit of keratinocytes
from the stem cell compartment (Dellambra et al, 2000;
Pellegrini et al, 2001). Functional inactivation of 14-3-3s by
antisense expression led to continued proliferation and im-
mortalization of keratinocytes, presumably by preventing
the exit from the stem cell state. This view is supported by
the continued expression of a p63 isoform specific for ker-
atinocyte stem cells in 14-3-3s-negative keratinocytes
(Pellegrini et al, 2001).
Now, two publications by Ghahary et al (2004a, b) in this
journal provide evidence for unexpected, additional func-
tions of the s isoform of 14-3-3 proteins in epidermal ker-
atinocytes: when keratinocytes were co-cultured with
fibroblasts, a situation which mimics wound healing proc-
esses, a dramatic increase in collagenase (also known as
matrix metalloproteinase 1 (MMP1), expression was de-
tected in the fibroblasts. In addition, collagenase activity as
determined by the breakdown of collagen 1 was detected in
media from fibroblasts co-cultured with keratinocytes
but not when fibroblasts were cultured separately. Through
a series of biochemical fractionations and mass-spect-
rometry, 14-3-3s was identified as a factor secreted by kera-
tinocytes required to mediate the concentration- and
time-dependent induction of MMP1 in fibroblast observed
after addition of conditioned keratinocyte medium (Ghahary
et al, 2004a). Recombinant 14-3-3s was found to be suf-
ficient to induce MMP1 expression in fibroblasts. In a fol-
low-up study published this issue, Ghahary et al (2004b),
describe the secretion of 14-3-3s as restricted to differen-
tiated keratinocytes, whereas in proliferating, undiffer-
entiated keratinocytes 14-3-3s expression is strictly
intracellular. Removal of 14-3-3s from conditioned media
abolished the expression of MMP1 in fibroblasts, implying
that 14-3-3s is necessary for the MMP1 expression-stim-
ulating effect of conditioned media obtained from keratin-
ocytes. This experiment was, however, performed using a
filter with a 30 kDa cutoff, which presumably also affected
other proteins besides 14-3-3s.
It has been known for some time that certain 14-3-3
isoforms are present in extracellular environments, such as
in cerebrospinal fluid (CSF). The presence of 14-3-3 pro-
teins in CSF has been associated with prion diseases such
as Creutzfeld–Jakob disease and other neurological dis-
orders (reviewed in Berg et al, 2003). A biological function of
these extracellular 14-3-3 proteins has, however, so far
been elusive. The presence of the 14-3-3 isoforms in CSF
has been largely attributed to their release during the des-
integration of neurons affected in the respective brain dis-
eases. It remains, however, to be shown that these
isoforms, in addition to their intracellular function, have a
specific extracellular function, which may contribute to the
etiology of the respective diseases. The stimulation of col-
lagenase expression in fibroblasts described by Ghahary
et al is the first indication of a biological function for extra-
cellular 14-3-3 proteins.
The new observations by Ghahary et al raise a number of
questions: How is 14-3-3s secreted? As 14-3-3s does not
harbor any typical amino-terminal ER export signal, the
route of its externalization still remains to be determined.
Other releasable factors like interleukin-1, FGF-2, and end-
othelial cell growth factor, however, also lack obvious signal
peptides. Ghahary et al excluded that 14-3-3s is simply
released due to cell lysis, as lactate dehydrogenase was not
detected in the media. It seems possible that 14-3-3s
may, however, be released during the differentiation proc-
ess of keratinocytes in the upper epidermis in vivo, which
culminates in granular cell death with destruction of all or-
ganelles and the formation of a cornified envelope by cova-
lent cross-linking of precursor proteins through the action of
calcium-dependent transglutaminases. In vitro the release
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of 14-3-3s seems to be actively regulated as 14-3-3s was
only found in conditioned media obtained from differentiat-
ed keratinocytes, although proliferating keratinocytes also
express similar 14-3-3s levels. During wound healing this
release of 14-3-3s may ensure that fibrogenic processes
are terminated with the onset of epithelialization and ker-
atinocyte differentiation.
The mechanisms underlying the stimulation of MMP1
expression by 14-3-3s are still obscure. Does extracellular
14-3-3s bind to a specific receptor on the cell surface of
fibroblasts? 14-3-3 proteins have been implicated in a
plethora of cellular processes by binding to a consensus
recognition motif that has to be phosphorylated at a serine
or threonine residue. Several phosphorylation-independent
14-3-3/ligand interactions have, however, been described.
The latter mode of ligand binding seems to be more likely
for the interaction of 14-3-3s with a putative receptor pre-
sented on the cell surface. Another unanswered question is
whether the secreted 14-3-3 protein exists as a monomer or
forms a dimer, which is necessary for interaction with phos-
phorylated 14-3-3-consensus motifs.
We recently found that several skin diseases character-
ized by hyperproliferative keratinocytes show high expres-
sion of the 14-3-3s protein: actinic keratosis, condylomata,
psoriasis, and squamos cell carcinoma (Lodygin et al,
2003). Whether 14-3-3s is also secreted in these scenarios
remains to be determined. If this is the case, it would be
important to determine whether extracellular 14-3-3s con-
tributes to the etiology of these diseases through influenc-
ing the expression of MMP1 and other genes in the
surrounding stromal fibroblasts.
On the other hand, a large number of invasive carcino-
mas, including basal cell carcinoma (BCC; Lodygin et al,
2003), prostate cancer (Lodygin et al, 2004), ovarian
(Mhawech et al, 2004), and breast cancer (Ferguson et al,
2000), show a high frequency of epigenetic silencing of the
14-3-3s gene by CpG-methylation (reviewed in Hermeking,
2003). This loss of 14-3-3s expression occurs in early stag-
es of cancer development (Hermeking, 2003; Lodygin et al,
2004). In the future, it will be interesting to determine
whether the potential loss of extracellular 14-3-3s expres-
sion may influence tumor/stroma interactions and thereby
contribute to tumor development and progression. As 14-3-
3s is expressed in all epithelial cells, it is conceivable that
the observation of Ghahary et al also applies to other or-
gans. The questions raised by the unexpected findings
made by Ghahary et al, should provide a fertile ground for
future research.
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